Publikationen | Institut für Hämatopathologie Hamburg

Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary

Cancer of unknown primary (CUP), CDKN2A, FGFR4, NOTCH1, TP53

Bochtler et al. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. Int J Cancer 2020; Jun 1;146(11):3053-3064. doi: 10.1002/ijc.32882. Epub 2020 Mar 11

Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors

Histogenese Extraoculares Talkdrüsenkarzinom, Histogenesis of extraocular sebaceous carcinoma

Boecker W et al. Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors. Am J Dermatopathol 2020; Jun 15. DOI: 10.1097/DAD.0000000000001667

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

acquired resistance mechanisms, EGFR p.T790M, EGFR Tyrosinekinaseinhibitor (TKI), EGFR tyrosine kinase inhibitors (TKI), Her2 Amplifikation, Her2 amplification, MET Amplifikation, MET amplification, multiplexed targeted sequencing (NGS), Tumorresistenz

Wagener-Ryczek S et al. Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors. BMC Cancer 2020; May 12;20(1):408. doi: 10.1186/s12885-020-06920-3

Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials

Extended field, Intestinal lymphoma, Intestinale Lymphome, Involved field, Involved site radiation therapy, Normal tissue complication probability, Radiotherapie Lymphome

Reinartz G et al. Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials. Oncologist 2020; May;25(5):e816-e832. doi: 10.1634/theoncologist.2019-0783

Adenosquamous Carcinoma of the Pancreas Comprise a Heterogeneous Group of Tumors With the Worst Outcome: A Clinicopathological Analysis of 25 Cases Identified in 562 Pancreatic Carcinomas Resected With Curative Intent

Adenosquamöses Karzinom des Pankreas, Adenosquamous carcinoma of the pancreas, ASCAP, K5/14, p63

Boecker W et al. Adenosquamous Carcinoma of the Pancreas Comprise a Heterogeneous Group of Tumors With the Worst Outcome: A Clinicopathological Analysis of 25 Cases Identified in 562 Pancreatic Carcinomas Resected With Curative Intent. Pancreas 2020; May/Jun 2020;49(5):683-691. doi: 10.1097/MPA.0000000000001548

Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC

Anti-angiogenic, vascular endothelial growth factor (VEGF)

Volz C et al. Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC. Cell Rep 2020; Apr 28;31(4):107568. doi: 10.1016/j.celrep.2020.107568

Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease

Angioimmunoblastic T-cell lymphoma, Angioimmunoblastisches T-Zell-Lymphom, Hodgkin lymphoma, HodgkinLymphom, Ligand PD-L1, Receptor PD-1, Rezeptor PD-1

Tiemann M et al. Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease. BMC Res Notes 2020; Mar 7;13(1):139. DOI: 10.1186/s13104-020-04975-w